High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT (GITMO-HLA-HR)
High Resolution Donor Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: the Italian Experience
Sponsor: Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)
This observational or N/A phase trial investigates Hematologic Diseases and is currently completed. Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT) leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Sep 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Dec 2019 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Sep 2019 — Dec 2019 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Sep 2019 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)
- Gruppo Italiano Trapianto di Midollo Osseo
- National Marrow Donor Program
- University of Rome Tor Vergata
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alessandria, Italy , Ancona, Italy , Ascoli Piceno, Italy , Bari, Italy , Bergamo, Italy , Bologna, Italy , Brescia, Italy , Cagliari, Italy , Catania, Italy , Cuneo, Italy and 20 more locations